Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review

@article{Molero2018AntidepressantEA,
  title={Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review},
  author={P. Molero and J. Ramos‐Quiroga and R. Mart{\'i}n-Santos and E. Calvo-S{\'a}nchez and L. Guti{\'e}rrez-Rojas and J. Meana},
  journal={CNS Drugs},
  year={2018},
  volume={32},
  pages={411-420}
}
  • P. Molero, J. Ramos‐Quiroga, +3 authors J. Meana
  • Published 2018
  • Medicine
  • CNS Drugs
    • Ketamine and its enantiomer S-ketamine (esketamine) are promising candidates to produce a rapid-onset antidepressant effect in treatment-resistant depression. Ketamine causes continued blockade of the glutamate N-methyl-d-aspartate (NMDA) receptor, though this might not primarily mediate the antidepressant effect. Alternative hypotheses include selectivity for the NMDA receptor subtype containing the NMDA receptor subunit 2B (NR2B), inhibition of the phosphorylation of the eukaryotic elongation… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    66 Citations
    Highly Influential Citations
    1
    Background Citations
    19
    Methods Citations
    1

    Paper Mentions

    Interventional Clinical Trial
    Low-dose S-ketamine in Women With Prenatal Depression
    Prenatal depression is an important risk factor of postpartum depression. Low-dose ketamine has been used for depression treatment. As a stereoisomer of ketamine, s-ketamine has similar… Expand
    ConditionsKetamine, Postpartum Depression, Prenatal Depression
    InterventionDrug
    Peking University First Hospital
    July 2020 - August 2021
    News Article
    Arketamine: A Fast-Acting Antidepressant Without Dissociative Effects?
    Benzinga
    26 March 2020
    66 Citations
    Citation Type

    Citation Type

    Antidepressant Actions of Ketamine and Its Two Enantiomers
    Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
    • 2
    Repurposing Potential of Ketamine: Opportunities and Challenges
    • 3
    Rapid-Acting Antidepressants.
    • 19
    Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
    • 39
    • PDF
    Intranasal esketamine in treatment-resistant depression: a profile of its use
    A Randomized Trial of the N-methyl-d-aspartate Receptor Glycine Site Antagonist Prodrug 4-chlorokynurenine in Treatment-Resistant Depression.
    • 6
    Antidepressant actions of ketamine. Nobel action mechanisms in the search of antidepressant drugs
    Ketamine in the Treatment of Depressive Episodes.
    • 2
    Structural Plasticity Induced by Ketamine in Human Dopaminergic Neurons as Mechanism Relevant for Treatment-Resistant Depression

    References

    SHOWING 1-10 OF 58 REFERENCES
    Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.
    • 116
    • PDF
    Mechanisms of ketamine action as an antidepressant
    • 186
    • PDF
    R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
    • 267
    Convergent Mechanisms Underlying Rapid Antidepressant Action
    • 72
    NMDAR inhibition-independent antidepressant actions of ketamine metabolites
    • 742
    • Highly Influential
    • PDF
    Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
    • 171
    • PDF
    Ketamine for Treatment-Resistant Unipolar Depression
    • 76
    Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions.
    • C. Andrade
    • Medicine
    • The Journal of clinical psychiatry
    • 2017
    • 22
    Mechanistic Target of Rapamycin–Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model
    • 94
    ON or OFF?: Modulating the N-Methyl-D-Aspartate Receptor in Major Depression
    • 17
    • PDF